Piper Sandler & Co’s Incyte INCY Stock Holding History

Piper Sandler & Co’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-201	Closed	-$22K	–	22
2015 Q4	$22K	Buy	+201	New	+$22.4K	0.06%	23

Other funds holding INCY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Piper Sandler & Co's INCY Position: Q1 2016 in Review

Piper Sandler & Co sold out of Incyte (INCY) in Q1 2016, closing a stake of 201 shares — an estimated $22K sold.

Piper Sandler & Co first reported a position in INCY in Q4 2015 and held it in 1 quarter. The position peaked at $22K in Q4 2015. 358 funds tracked by Wall St. Rank hold INCY as of Q1 2016.

Piper Sandler & Co reported no remaining Incyte position as of Q1 2016 after selling out during the quarter.
Piper Sandler & Co sold 201 Incyte shares in Q1 2016, an estimated $22K.
Piper Sandler & Co first reported a position in Incyte in Q4 2015 and held it in 1 quarter.
Piper Sandler & Co's Incyte position peaked at $22K in Q4 2015.
358 funds tracked by Wall St. Rank held Incyte as of Q1 2016.

Based on Piper Sandler & Co's 13F filing for Q1 2016, filed 16 May 2016.